Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Symetryx Corp Insider Profile
4 Followers
Symetryx Corp, Ten Percent Owner at NeuBase Therapeutics, holds 0.00 shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Symetryx Corp Sold $282,445 shares of NeuBase Therapeutics on Sep 18, 2023 for an estimated value of 375.62K.
Symetryx Corp NeuBase Therapeutics (NBSE)Ten Percent Owner
NeuBase Therapeutics (NBSE)
Ten Percent Owner
Not Ranked
Ranked #20,169 out of 99,635 Corporate Insiders
Symetryx Corp has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Symetryx Corp does not currently own shares as a corporate insider.
A breakdown of Symetryx Corp's holdings
Insider Roles
Symetryx Corp does not currently hold a role as a corporate insider.
Roles that Symetryx Corp holds in companies
Most Profitable Insider Trade
Stock:
NeuBase Therapeutics
(NBSE)
(NBSE)
Rating:Informative Buy
Date:Sep 07, 2023 - Sep 07, 2024
Return:-29.90%
The most profitable trade made by Symetryx Corp
Symetryx Corp's Trading History
List of latest transactions for each holding click on a transaction to see Symetryx Corp's performance on stock
You May Also Like
Symetryx Corp insider profile FAQ
What is the percentage of profitable transactions made by Symetryx Corp?
The percentage of profitable transactions made by Symetryx Corp is ―.
What is the average return per transaction made by Symetryx Corp?
The average return per transaction made by Symetryx Corp is ―.
What stocks does Symetryx Corp hold?
Symetryx Corp holds: NBSE stocks.
What was Symetryx Corp’s latest transaction?
Symetryx Corp latest transaction was an Informative Sell of $375.62K.
What was Symetryx Corp's most profitable transaction?
Symetryx Corp’s most profitable transaction was an Informative Buy of NBSE stock on September 7, 2023. The return on the trade was -29.90%.
What is Symetryx Corp's role in NeuBase Therapeutics?
Symetryx Corp's role in NeuBase Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.